Covered recipient · General Payments record
JESSICA MON CHIN TAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$1,796.51
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $860.51 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $358.61 | 18 |
| Medtronic, Inc. | $214.58 | 5 |
| IBSA Pharma Inc. | $94.71 | 4 |
| Ardelyx, Inc. | $79.97 | 3 |
| Exact Sciences Corporation | $39.49 | 2 |
| PFIZER INC. | $27.86 | 1 |
| Phathom Pharmaceuticals, Inc. | $24.24 | 1 |
| Novo Nordisk AS | $21.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.10 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461240 | CMS |
| ABBVIE INC. | $9.00 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461242 | CMS |
| ABBVIE INC. | $28.87 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461244 | CMS |
| ABBVIE INC. | $15.00 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461246 | CMS |
| ABBVIE INC. | $30.61 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461248 | CMS |
| ABBVIE INC. | $27.27 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461250 | CMS |
| ABBVIE INC. | $21.15 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461252 | CMS |
| ABBVIE INC. | $21.57 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461254 | CMS |
| ABBVIE INC. | $14.23 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461256 | CMS |
| ABBVIE INC. | $12.98 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461258 | CMS |
| ABBVIE INC. | $29.36 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461260 | CMS |
| ABBVIE INC. | $10.95 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461262 | CMS |
| ABBVIE INC. | $23.08 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461264 | CMS |
| ABBVIE INC. | $22.37 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461266 | CMS |
| ABBVIE INC. | $18.31 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461268 | CMS |
| ABBVIE INC. | $21.18 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461270 | CMS |
| ABBVIE INC. | $11.32 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461272 | CMS |
| ABBVIE INC. | $21.26 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103461274 | CMS |
| Ardelyx, Inc. | $24.60 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146675418 | CMS |
| Ardelyx, Inc. | $30.81 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146675420 | CMS |
| Ardelyx, Inc. | $24.56 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146675422 | CMS |
| Exact Sciences Corporation | $17.96 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114614694 | CMS |
| Exact Sciences Corporation | $21.53 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114614698 | CMS |
| IBSA Pharma Inc. | $24.94 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980259 | CMS |
| IBSA Pharma Inc. | $24.89 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980261 | CMS |
| IBSA Pharma Inc. | $21.39 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980263 | CMS |
| IBSA Pharma Inc. | $23.49 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142974491 | CMS |
| Medtronic, Inc. | $34.62 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119298239 | CMS |
| Medtronic, Inc. | $10.30 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119298233 | CMS |
| Medtronic, Inc. | $100.96 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119298235 | CMS |
| Medtronic, Inc. | $58.40 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119298237 | CMS |
| Medtronic, Inc. | $10.30 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119298231 | CMS |
| Novo Nordisk Inc | $21.05 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097129618 | CMS |
| PFIZER INC. | $27.86 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131859941 | CMS |
| Phathom Pharmaceuticals, Inc. | $24.24 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151049488 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.